The start-up biomedical company Carmat is assembling a completely artificial heart which it says will be ready for use by 2011. Backed by the noted French scientist Alain Carpentier, the VC group Truffle and the French innovation agency, Carmat will develop the new heart in a facility close to Paris. Report